A class or aromatic ketone consisting of acetophenone, PhC(=O)CH3, and its substituted derivatives.
ChEBI ID: 22187
Member | Definition | Role |
---|---|---|
(R)-Bitalin A | (R)-Bitalin A | |
3,4-dihydroxyacetophenone | 3,4-dihydroxyacetophenone; 3',4'-dihydroxyacetophenone | |
4-acetylanisole | A member of the class of acetophenones that is acetophenone substituted by a methoxy group at position 4. | 4-methoxyacetophenone |
4-hydroxypropiophenone | p-Hydroxypropiophenone | |
4-nitroacetophenone | A member of the class of acetophenones that is acetophenone substituted at the para-position by a nitro group. | 4-nitroacetophenone |
acetohexamide | An N-sulfonylurea that is urea in which a hydrogen attached to one of the nitrogens is replaced by a p-acetylphenylsulfonyl group, while a hydrogen attached to the other nitrogen is replaced by a cyclohexyl group. | acetohexamide |
acetophenone | A methyl ketone that is acetone in which one of the methyl groups has been replaced by a phenyl group. | acetophenone |
acetosyringone | A member of the class of acetophenones that is 1-phenylethanone substituted by a hydroxy group at position 4 and methoxy groups at positions 3 and 5. | acetosyringone |
acetovanillone | An aromatic ketone that is 1-phenylethanone substituted by a hydroxy group at position 4 and a methoxy group at position 3. | apocynin |
acrovestone | A polyphenol that is isolated from Acronychia pedunculata and exhibits moderate antioxidant and antityrosinase activities. | acrovestone |
ly 171883 | A member of the class of acetophenones that is 1-phenylethanone substituted at position 2 by a hydroxy group, a propyl group at position 3 and a 4-(1H-tetrazol-5-yl)butoxy group at position 4. A leukotriene antagonist, it exhibits anti-asthmatic activity. | tomelukast |
phenacyl bromide | An alpha-bromoketone that is acetophenone substituted by a bromo group at position 2. | phenacyl bromide |
u 0521 | U 0521 |
Timeframe | Studies, Drugs in This Class (%) | All Drugs % |
---|---|---|
pre-1990 | 441 (20.51) | 18.7374 |
1990's | 209 (9.72) | 18.2507 |
2000's | 501 (23.30) | 29.6817 |
2010's | 850 (39.53) | 24.3611 |
2020's | 149 (6.93) | 2.80 |
Publication Type | Studies, Drugs in This Class (%) | All Drugs (%) |
---|---|---|
Trials | 23 (1.00%) | 5.53% |
Reviews | 58 (2.52%) | 6.00% |
Case Studies | 23 (1.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 2,199 (95.48%) | 84.16% |